News about Industrial talks

Cipla's OSD plant bags Global Lighthouse Network recognition

Cipla deployed 'Digital Automation Analytics' (DAA) across a network of 22 India sites in parallel to unlock end-to-end costs, productivity and quality leadership

Industrial talks | 12/10/2022 | By Sudeep Soparkar |  1398

Lupin appoints Shahin Fesharaki as Global Chief Scientific Officer

Fesharaki will be in charge of Lupin's global R&D operations spanning branded, generic, and speciality products

Industrial talks | 07/10/2022 | By Sudeep Soparkar |  585

Supriya Lifescience appoints Rajeev Kumar Jain as CEO

He has over 35+ years of rich functional experience in the manufacturing domain of bulk drugs, intermediate and API

Industrial talks | 03/10/2022 | By Sudeep Soparkar |  935

Piramal Pharma appoints Vibha Paul Rishi to its Board of Directors

Rishi is a marketing professional and has held global leadership positions across branding, strategy, innovation and human capital

Industrial talks | 30/09/2022 | By Sudeep Soparkar |  913

Jiuzhou Pharma to buy Sandoz finished drugs plant in Zhongshan for $15.1 M

The Chinese firm also plans to refurbish and expand the facility, altogether redirecting $18.5 million of capital to the Sandoz project.<br />

Industrial talks | 29/09/2022 | By Sudeep Soparkar |  809

Biopharmaceutical company Ipsen unveils 52 M Euro expansion plan

The investment is aimed at boosting medicine and ingredient production in cancer and rare disease space

Industrial talks | 28/09/2022 | By Sudeep Soparkar |  750

OPPI appoints Suresh Pattathil as president

Suresh Pattathil succeeds S Sridhar who has been the President of OPPI since February 2021

Industrial talks | 27/09/2022 | By Sudeep Soparkar |  789

Sekhmet Pharmaventures buys stake in Hyd-based Optimus Group

Optimus, a manufacturer of pharmaceutical goods with vertical integration that includes advanced intermediates, active pharmaceutical ingredients etc

Industrial talks | 27/09/2022 | By Sudeep Soparkar |  1922

IQVIA Market Reflection Report - JB Pharma

IQVIA Market Reflection Report pins JB Pharma as the fastest growing Pharma Company with a growth rate of over 20% for the month of August 2022

Industrial talks | 22/09/2022 | By Sudeep Soparkar |  923

Mankind Pharma files DRHP with SEBI

The company’s initial public offering comprises an offer for the sale of 40,058,884 equity shares of face value Rs 1

Industrial talks | 19/09/2022 | By Sudeep Soparkar |  635